DK0782573T3 - Brefeldin og analoger til forbedret synaptisk transmission - Google Patents

Brefeldin og analoger til forbedret synaptisk transmission

Info

Publication number
DK0782573T3
DK0782573T3 DK95930845T DK95930845T DK0782573T3 DK 0782573 T3 DK0782573 T3 DK 0782573T3 DK 95930845 T DK95930845 T DK 95930845T DK 95930845 T DK95930845 T DK 95930845T DK 0782573 T3 DK0782573 T3 DK 0782573T3
Authority
DK
Denmark
Prior art keywords
brefeldin
analogs
synaptic transmission
enhanced synaptic
enhanced
Prior art date
Application number
DK95930845T
Other languages
English (en)
Inventor
Katumi Sumikawa
Ken-Ichi Ito
James L Mcgaugh
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK0782573T3 publication Critical patent/DK0782573T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95930845T 1994-09-20 1995-08-16 Brefeldin og analoger til forbedret synaptisk transmission DK0782573T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30987194A 1994-09-20 1994-09-20
PCT/US1995/010454 WO1996009299A1 (en) 1994-09-20 1995-08-16 Drugs to improved synaptic transmission

Publications (1)

Publication Number Publication Date
DK0782573T3 true DK0782573T3 (da) 2000-06-05

Family

ID=23200041

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95930845T DK0782573T3 (da) 1994-09-20 1995-08-16 Brefeldin og analoger til forbedret synaptisk transmission

Country Status (11)

Country Link
US (2) US6710073B1 (da)
EP (1) EP0782573B1 (da)
JP (1) JPH10508579A (da)
KR (1) KR970706271A (da)
AT (1) ATE190056T1 (da)
AU (1) AU703667B2 (da)
DE (1) DE69515321T2 (da)
DK (1) DK0782573T3 (da)
ES (1) ES2143068T3 (da)
NO (1) NO315929B1 (da)
WO (1) WO1996009299A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001512422A (ja) * 1997-02-05 2001-08-21 アレリツクス・フアーム−エコ・エル・ピー 記憶増強のための薬剤
GB0117645D0 (en) * 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
WO2009019032A2 (en) * 2003-08-08 2009-02-12 Dsm Ip Assets B.V. Novel method for screening brain-active compounds
ES2572831T3 (es) 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
DK2708147T3 (da) * 2012-09-14 2020-05-18 Abbott Lab Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose
CN112851622B (zh) 2019-11-28 2023-01-10 中国海洋大学 一种大环内酯布雷菲德菌素a酯类衍生物及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5611710B2 (da) * 1972-09-13 1981-03-16
JPS57159710A (en) * 1981-03-28 1982-10-01 Koki Yagishita Antifungal germicide
DE3247379A1 (de) * 1982-12-22 1984-06-28 Basf Ag, 6700 Ludwigshafen Brefeldin-a-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
MW187A1 (en) * 1986-01-23 1987-10-14 Hoffmann La Roche Benzazecine derivatives
US5214039A (en) * 1990-02-02 1993-05-25 Taiho Pharmaceutical Co., Limited Bicyclolactam derivative for improving cerebral function
US5242932A (en) 1991-12-17 1993-09-07 The Rockefeller University Treatment of amyloidosis associated with alzheimer disease
DE4305249A1 (de) * 1993-02-20 1994-08-25 Hoechst Ag Galaktosylbrefeldin A, ein neuer Metabolit mit pharmakologischer Wirkung, ein Verfahren zu seiner Herstellung und seine Verwendung

Also Published As

Publication number Publication date
EP0782573B1 (en) 2000-03-01
KR970706271A (ko) 1997-11-03
US6710073B1 (en) 2004-03-23
AU703667B2 (en) 1999-04-01
DE69515321T2 (de) 2000-08-24
WO1996009299A1 (en) 1996-03-28
JPH10508579A (ja) 1998-08-25
EP0782573A4 (en) 1998-01-14
AU3407695A (en) 1996-04-09
NO315929B1 (no) 2003-11-17
US20040242553A1 (en) 2004-12-02
NO971274L (no) 1997-03-19
DE69515321D1 (de) 2000-04-06
NO971274D0 (no) 1997-03-19
ES2143068T3 (es) 2000-05-01
US7081474B2 (en) 2006-07-25
ATE190056T1 (de) 2000-03-15
EP0782573A1 (en) 1997-07-09

Similar Documents

Publication Publication Date Title
NO983266L (no) Distribuert Behandling
DK1275391T3 (da) Farmaceutiske sammensætninger indeholdende irbesartan og et diuretikum
DK0508658T4 (da) Aseptisk ventilkonstruktion
NL194741B (nl) Seismische bronnenreeks voor gebruik bij maritieme seismische opsporing.
DE69415126D1 (de) Gegenflusspipelineprozessor
DE69225596D1 (de) Rohruntersuchungsventil
DE69204933D1 (de) Rohrabsperrvorrichtung.
MC2112A1 (fr) Comprime effervescent
DK0782573T3 (da) Brefeldin og analoger til forbedret synaptisk transmission
FR2515405B1 (fr) Registre a decalage dynamique rapide utilisant des transistors mes
FI943120A7 (fi) Alfa-substituoituja bentseenimetanamiinijohdannaisia
DE69206031D1 (de) Tablettierhilfsstoff.
MX9201944A (es) Formulacion farmaceutica que contiene diritromicina.
DE69202124D1 (de) Neue Vitamin-D3-Derivate.
IT230189Y1 (it) Dispositivo per mantenere fresca una bottiglia.
DE59202012D1 (de) Absperrdichtung.
ES2105930B1 (es) Puya de picador perfeccionada.
DE68914434D1 (de) Doppelzylinder bioreaktor.
KR930006485U (ko) 미술대 입시용 뎃생교재
ES1030301Y (es) Muñeco perfeccionado que simula beber.
KR930010703U (ko) 학습용 노트
ES1031631Y (es) Dispositivo para producir efectos especiales en carteles.
ES1031632Y (es) Dispositivo para producir efectos especiales en carteles.
ES1031633Y (es) Dispositivo para producir efectos especiales en carteles.
KR950019652U (ko) 유압 실린더의 패킹 분해 장치